1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Uveal Melanoma Global Clinical Trials Review, H1, 2015

Uveal Melanoma Global Clinical Trials Review, H1, 2015

  • March 2015
  • -
  • Global Data
  • -
  • 70 pages

Uveal Melanoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Uveal Melanoma Global Clinical Trials Review, H1, 2015" provides data on the Uveal Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uveal Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Uveal Melanoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Uveal Melanoma Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Uveal Melanoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Uveal Melanoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Uveal Melanoma 21
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Uveal Melanoma Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Novartis AG 29
Clinical Trial Overview of Novartis AG 29
Eli Lilly and Company 30
Clinical Trial Overview of Eli Lilly and Company 30
AstraZeneca PLC 31
Clinical Trial Overview of AstraZeneca PLC 31
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Spectrum Pharmaceuticals, Inc. 33
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 33
Polaris Pharmaceuticals, Inc. 34
Clinical Trial Overview of Polaris Pharmaceuticals, Inc. 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of Top Institutes / Government 36
National Cancer Institute 36
Clinical Trial Overview of National Cancer Institute 36
Charite - Universitatsmedizin Berlin 37
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 37
Memorial Sloan Kettering Cancer Center 38
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 38
The University of Texas M. D. Anderson Cancer Center 39
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 39
Thomas Jefferson University 40
Clinical Trial Overview of Thomas Jefferson University 40
Case Comprehensive Cancer Center 41
Clinical Trial Overview of Case Comprehensive Cancer Center 41
Radboud University 42
Clinical Trial Overview of Radboud University 42
The Clatterbridge Cancer Centre NHS Foundation Trust 43
Clinical Trial Overview of The Clatterbridge Cancer Centre NHS Foundation Trust 43
Alberta Health Services 44
Clinical Trial Overview of Alberta Health Services 44
Barnes Retina Institute 45
Clinical Trial Overview of Barnes Retina Institute 45
Five Key Clinical Profiles 46
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70

List of Tables
Uveal Melanoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Uveal Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Uveal Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Uveal Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Uveal Melanoma Therapeutics, Global, Suspended Clinical Trials, 2015* 21
Uveal Melanoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 22
Uveal Melanoma Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 29
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 30
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 31
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 32
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2015* 33
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Polaris Pharmaceuticals, Inc., 2015* 34
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 36
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015* 37
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 38
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015* 39
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015* 40
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 41
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015* 42
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Clatterbridge Cancer Centre NHS Foundation Trust, 2015* 43
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2015* 44
Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2015* 45

List of Figures
Uveal Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Uveal Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.